And it so happened that just months before Emily was admitted to the hospital, a new therapy had been approved by the FDA to treat elevated levels of interleukin-6.
Nur Monate, bevor Emily ins Krankenhaus kam, ließ man ein neues Medikament zur Behandlung erhöhter IL-6-Werte zu,